These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9987703)

  • 1. Lack of effect of erythromycin and ketoconazole on the pharmacokinetics and pharmacodynamics of steady-state intranasal levocabastine.
    Pesco-Koplowitz L; Hassell A; Lee P; Zhou H; Hall N; Wiesinger B; Mechlinski W; Grover M; Hunt T; Smith R; Travers S
    J Clin Pharmacol; 1999 Jan; 39(1):76-85. PubMed ID: 9987703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loratadine administered concomitantly with erythromycin: pharmacokinetic and electrocardiographic evaluations.
    Brannan MD; Reidenberg P; Radwanski E; Shneyer L; Lin CC; Cayen MN; Affrime MB
    Clin Pharmacol Ther; 1995 Sep; 58(3):269-78. PubMed ID: 7554700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desloratadine has no clinically relevant electrocardiographic or pharmacodynamic interactions with ketoconazole.
    Banfield C; Herron J; Keung A; Padhi D; Affrime M
    Clin Pharmacokinet; 2002; 41 Suppl 1():37-44. PubMed ID: 12169045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-administration of ketoconazole with H1-antagonists ebastine and loratadine in healthy subjects: pharmacokinetic and pharmacodynamic effects.
    Chaikin P; Gillen MS; Malik M; Pentikis H; Rhodes GR; Roberts DJ
    Br J Clin Pharmacol; 2005 Mar; 59(3):346-54. PubMed ID: 15752381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the pharmacokinetics and electrocardiographic pharmacodynamics of loratadine with concomitant administration of ketoconazole or cimetidine.
    Kosoglou T; Salfi M; Lim JM; Batra VK; Cayen MN; Affrime MB
    Br J Clin Pharmacol; 2000 Dec; 50(6):581-9. PubMed ID: 11136297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of levocabastine nasal spray for seasonal allergic rhinitis.
    Hampel FC; Martin BG; Dolen J; Travers S; Karcher K; Holton D
    Am J Rhinol; 1999; 13(1):55-62. PubMed ID: 10088031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of clinically relevant interaction between desloratadine and erythromycin.
    Banfield C; Hunt T; Reyderman L; Statkevich P; Padhi D; Affrime M
    Clin Pharmacokinet; 2002; 41 Suppl 1():29-35. PubMed ID: 12169044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacokinetic properties of topical levocabastine. A review.
    Heykants J; Van Peer A; Van de Velde V; Snoeck E; Meuldermans W; Woestenborghs R
    Clin Pharmacokinet; 1995 Oct; 29(4):221-30. PubMed ID: 8549024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prokinetic cinitapride has no clinically relevant pharmacokinetic interaction and effect on QT during coadministration with ketoconazole.
    Robert M; Salvà M; Segarra R; Pavesi M; Esbri R; Roberts D; Golor G
    Drug Metab Dispos; 2007 Jul; 35(7):1149-56. PubMed ID: 17437965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics, Safety, and Tolerability of Once-Daily Intranasal Fluticasone Furoate and Levocabastine Administered Alone or Simultaneously as fluticasone Furoate/Levocabastine Fixed-Dose Combination.
    Allen A; Murdoch RD; Bareille P; Burns O; Hughes S; Gupta A; Miller SR
    Clin Pharmacol Drug Dev; 2016 May; 5(3):225-31. PubMed ID: 27163502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Onset and duration of action of levocabastine nasal spray in atopic patients under nasal challenge conditions.
    Corren J; Rachelefsky G; Spector S; Schanker H; Siegel S; Holton D; Karcher K; Travers S
    J Allergy Clin Immunol; 1999 Apr; 103(4):574-80. PubMed ID: 10200003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of significant effect of bilastine administered at therapeutic and supratherapeutic doses and concomitantly with ketoconazole on ventricular repolarization: results of a thorough QT study (TQTS) with QT-concentration analysis.
    Tyl B; Kabbaj M; Azzam S; Sologuren A; Valiente R; Reinbolt E; Roupe K; Blanco N; Wheeler W
    J Clin Pharmacol; 2012 Jun; 52(6):893-903. PubMed ID: 21642470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ketoconazole on the pharmacokinetics and safety of telithromycin and clarithromycin in older subjects with renal impairment.
    Shi J; Chapel S; Montay G; Hardy P; Barrett JS; Sica D; Swan SK; Noveck R; Leroy B; Bhargava VO
    Int J Clin Pharmacol Ther; 2005 Mar; 43(3):123-33. PubMed ID: 15792396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interaction of saquinavir (soft gelatin capsule) with ketoconazole, erythromycin and rifampicin: comparison of the effect in healthy volunteers and in HIV-infected patients.
    Grub S; Bryson H; Goggin T; Lüdin E; Jorga K
    Eur J Clin Pharmacol; 2001 May; 57(2):115-21. PubMed ID: 11417442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No clinically significant effect of erythromycin or azithromycin on the pharmacokinetics of voriconazole in healthy male volunteers.
    Purkins L; Wood N; Ghahramani P; Kleinermans D; Layton G; Nichols D
    Br J Clin Pharmacol; 2003 Dec; 56 Suppl 1(Suppl 1):30-6. PubMed ID: 14616411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal levocabastine for the treatment of seasonal allergic rhinitis: a multicentre, double-blind, placebo-controlled trial.
    Dahl R; Pedersen B; Larsen B
    Rhinology; 1995 Sep; 33(3):121-5. PubMed ID: 8560160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative efficacy and safety of azelastine and levocabastine nasal sprays in patients with seasonal allergic rhinitis.
    Falser N; Wober W; Rahlfs VW; Baehre M
    Arzneimittelforschung; 2001; 51(5):387-93. PubMed ID: 11413739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the effects of rifampicin, ketoconazole and erythromycin on the steady-state pharmacokinetics of the components of a novel oral contraceptive containing estradiol valerate and dienogest in healthy postmenopausal women.
    Blode H; Zeun S; Parke S; Zimmermann T; Rohde B; Mellinger U; Kunz M
    Contraception; 2012 Oct; 86(4):337-44. PubMed ID: 22445438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of age and gender on the pharmacokinetics of ebastine after single and repeated dosing in healthy subjects.
    Rohatagi S; Gillen M; Aubeneau M; Jan C; Pandit B; Jensen BK; Rhodes G
    Int J Clin Pharmacol Ther; 2001 Mar; 39(3):126-34. PubMed ID: 11396753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and electrocardiographic effect of ebastine in young versus elderly healthy subjects.
    Huang MY; Argenti D; Wilson J; Garcia J; Heald D
    Am J Ther; 1998 May; 5(3):153-8. PubMed ID: 10099053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.